The Contract Manufacturer Rework Policy: Questions to Ask Before Signing
You receive the Certificate of Analysis for your 50,000-unit commercial run of vitamin C gummies. Everything looks fine, except the active assay for vitamin C came back at 75% of the label claim. The manufacturer admits the cooking temperature was slightly too high, causing degradation.
What happens next defines the true value of your contract manufacturing organisation (CMO).
A good CMO halts production, isolates the batch, investigates the root cause, and manufactures a replacement batch at their own cost. A bad CMO attempts to ship it anyway, suggests you blend it with a stronger batch, or points to a tiny clause in your contract stating that a 25% variance is within their acceptable tolerance.
Understanding a contract manufacturer gummy rework policy is not a pessimistic exercise; it is essential risk management. Before you sign a Master Manufacturing Agreement (MMA), here are the questions you must ask about batch rejection, rework, and liability.
What Does "Rework" Mean in Gummy Manufacturing?
In pharmaceutical and high-tier nutraceutical manufacturing, "rework" has a very specific definition. It means taking a batch that has failed to meet a specification and subjecting it to an additional processing step to bring it back into compliance.
However, in gummy manufacturing, true rework is often physically impossible.
If a powder blend fails assay, you can sometimes add more of the deficient active ingredient and remix. If a gummy fails assay after it has been cooked, deposited, and cured, you cannot un-cook it. You cannot melt it down and start over without completely destroying the remaining vitamins, botanicals, or probiotics.
Therefore, in the context of gummies, a "rework policy" is usually a misnomer. What you are actually negotiating is a Batch Rejection and Replacement Policy.
The Four Common Scenarios for Gummy Batch Rejection
When discussing liability with a prospective CMO, you need to agree on what constitutes a "failure." Most gummy batch rejections fall into four categories:
1. Active Ingredient Assay Failure
The product does not meet the label claim for the active ingredients (e.g., too little vitamin D, or zero viable probiotic CFUs). This is the most critical failure and is entirely the manufacturer's responsibility if they developed the formulation and process.
2. Microbial Contamination
The batch fails microbiological testing (e.g., high total plate count, presence of yeast/mould, or specific pathogens like E. coli or Salmonella). This is a severe facility hygiene failure.
3. Physical Defect or Texture Failure
The gummies are too sticky, too hard, deformed, or have "wept" moisture in the bottle. This often happens if the curing room humidity was incorrect, or if the formulation's water activity was miscalculated.
4. Organoleptic Failure (Taste and Appearance)
The colour has turned muddy, or the flavour is unacceptably bitter compared to the approved pilot sample. This is subjective but critical for consumer acceptance.
Questions to Ask Your CMO Before Signing
Do not accept a generic "we stand behind our quality" statement. Ask these specific questions and look for the answers in the written contract.
Q1: What are your defined tolerance limits?
Every manufacturing process has variance. What is the acceptable +/- percentage for the active ingredients? A high-quality facility will typically aim for 100-110% of label claim (including necessary overages). If a CMO states their acceptable tolerance is +/- 20%, they are building in a massive margin for their own error.
Q2: If a batch fails the agreed specification, who pays for the replacement?
This must be explicitly stated. If the failure is due to a manufacturing error (wrong temperature, wrong mix time, poor hygiene), the CMO must absorb the cost of the raw materials, the machine time, and the packaging, and provide a replacement batch at no additional cost to you.
Q3: What happens if I supply the raw materials (Toll Manufacturing)?
If you buy an expensive, patented probiotic strain and ship it to the CMO, and the CMO ruins the batch by overheating it, will they reimburse you for the cost of the raw material? Many CMOs cap their liability at the cost of their processing fee, leaving you to absorb the loss of the expensive active ingredient. If you supply the materials, negotiate raw material liability.
Q4: How is a dispute over quality resolved?
If the CMO’s internal lab says the batch passes, but your independent third-party lab says it fails, who breaks the tie? A standard clause is to appoint a mutually agreed-upon independent referee lab.
Q5: Will you notify me of a deviation before the product is packaged?
A transparent CMO will flag a problem as soon as it happens - for instance, if the in-process weight checks are failing. A dishonest CMO will package the product and hope you don't notice. Ask to see their Standard Operating Procedure (SOP) for out-of-specification (OOS) investigations.
Learn about Probiotic Gummies Manufacturing
The Danger of "Blending"
Some lower-tier manufacturers attempt to solve a failed batch by blending.
If Batch A has only 50% of the required vitamin C, and Batch B has 150%, the manufacturer might propose mixing the bottles on the pallet, arguing that the average is 100%.
This is unacceptable in supplement manufacturing. It violates Good Manufacturing Practices (GMP) and guarantees that individual consumers will receive an inconsistent, non-compliant product. Your contract must explicitly forbid the blending of out-of-specification batches without your written consent.
Why Cheap CMOs Carry Hidden Risks
When you receive a quote that is dramatically lower than the competition, you must ask how the CMO is achieving that price. Often, it is by minimizing their own risk and passing it to the brand.
Cheap CMOs achieve lower prices by:
- Using wider tolerance limits (accepting a lower quality standard)
- Skipping in-process QC checks
- Refusing raw material liability
- Refusing to pay for third-party testing to verify their own results
A CMO that charges a fair market rate, operates a GMP-certified facility, and signs a contract accepting full liability for manufacturing errors is the cheaper option in the long run. A single rejected commercial batch from a cheap manufacturer will wipe out years of per-unit cost savings.
FAQ
Can a gummy manufacturer legally sell my rejected batch to someone else? If the batch is rejected for quality issues, it should be destroyed. However, if it's rejected for a branding issue (e.g., wrong colour) but is still safe, a shady CMO might try to sell it. Your contract must include an IP protection and destruction clause, stipulating that rejected batches bearing your custom formulation or brand name must be verifiably destroyed.
What is an OOS investigation? Out of Specification (OOS) is a formal QA process. If a test result falls outside the accepted parameters, the manufacturer must conduct a documented investigation to determine why it happened (equipment failure, human error, raw material issue) before deciding how to handle the batch. Ask your CMO if they provide OOS reports to clients.
If a batch is delayed because of a rework, does the CMO owe me a penalty? Some large brands negotiate Service Level Agreements (SLAs) with late delivery penalties. For startup and mid-market brands, it is very difficult to get a CMO to agree to financial penalties for delays. Focus your negotiation on ensuring they replace the defective batch rather than fighting for delay compensation.
Secure Your Supply Chain
If you are evaluating gummy manufacturers and want a partner who stands behind their quality with transparent batch-release criteria and clear liability policies, let's have a conversation.
We operate a US-FDA registered, GMP-compliant facility and build our client relationships on clear, fair manufacturing agreements that protect your brand equity.
Explore Functional Gummy Manufacturing Request a Project Brief
Want to discuss your formulation?
Our experts help brands launch technically complex probiotic and functional gummies.
